BBIO vs SRE · rev $438.2M vs P/E 31, rev $13.70B
BridgeBio Pharma Inc (BBIO) versus Sempra Energy (SRE) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Sempra Energy (SRE) is a utilities - diversified company listed on US.
Latest reported BBIO revenue for 2026-06-30 was $438.2M. Net income was -$322.4M. BBIO currently screens at market cap $13.24B.
Latest reported SRE revenue for 2025-12-31 was $13.70B. Net income was $1.84B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. SRE currently screens at market cap $59.76B and trailing P/E 31.1.
BBIO currently screens at market cap $13.24B. SRE currently screens at market cap $59.76B and trailing P/E 31.1.
Not investment advice. Open the BBIO and SRE stock pages for the full models.
Not investment advice.